- Presentations
- 2
- Markets
- 1
Benlysta is a brand of Belimumab marketed by GlaxoSmithKline, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Belimumab
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 200 mg/1 mL injection, 120 mg/1.5 mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Benlysta 200 mg/1 mL injectionSubcutaneous Cold chain | GlaxoSmithKline | US FDA | Available on request |
| Benlysta 120 mg/1.5 mL powder for injectionIntravenous Cold chain | GlaxoSmithKline | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Benlysta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.